To assess SGZ predictions of tumor zygosity, we selected the most frequently mutated somatic variants at oncogenes (BRAF, EGFR, IDH1, KRAS, NRAS, PIK3CA) and tumor suppressor genes (TP53, RB1, PTEN) for analysis. Here, EGFR is linked to neoplasm.